GRTS RSI Chart
Last 7 days
1.3%
Last 30 days
5.3%
Last 90 days
-63.4%
Trailing 12 Months
-58.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 15.6M | 0 | 0 | 0 |
2023 | 15.2M | 11.7M | 10.2M | 16.3M |
2022 | 15.7M | 18.3M | 18.7M | 19.9M |
2021 | 42.5M | 44.8M | 46.5M | 48.2M |
2020 | 4.3M | 3.6M | 3.6M | 4.0M |
2019 | 2.4M | 3.7M | 4.6M | 4.4M |
2018 | 0 | 0 | 0 | 1.2M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 01, 2024 | cho james | acquired | - | - | 18,000 | svp, chief accounting officer |
Feb 01, 2024 | allen andrew r | acquired | - | - | 105,000 | president and ceo |
Feb 01, 2024 | hawryluk matthew | acquired | - | - | 35,000 | evp, chief business officer |
Feb 01, 2024 | jooss karin | acquired | - | - | 40,000 | see remarks |
Feb 01, 2024 | economides vassiliki | acquired | - | - | 35,000 | evp, chief financial officer |
Feb 01, 2024 | jones erin | acquired | - | - | 40,000 | evp, chief operating officer |
May 23, 2023 | economides vassiliki | bought | 22,828 | 1.9024 | 12,000 | see remarks |
Feb 02, 2023 | economides vassiliki | acquired | - | - | 179,058 | see remarks |
Feb 02, 2023 | jones erin | acquired | - | - | 252,845 | see remarks |
Feb 02, 2023 | allen andrew r | acquired | - | - | 738,550 | president and ceo |
Which funds bought or sold GRTS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | Artal Group S.A. | new | - | 2,649,550 | 2,649,550 | 0.07% |
May 16, 2024 | Tidal Investments LLC | new | - | 63,058 | 63,058 | -% |
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -26.1 | -28,282 | 381,722 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -37.25 | -6,173 | 23,297 | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -61.62 | -47,000 | 44,000 | -% |
May 15, 2024 | Point72 Asset Management, L.P. | reduced | -22.64 | -206,321 | 7,902,410 | 0.02% |
May 15, 2024 | CITADEL ADVISORS LLC | reduced | -46.09 | -199,351 | 421,976 | -% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | added | 247 | 945,577 | 1,225,370 | -% |
May 15, 2024 | WEXFORD CAPITAL LP | sold off | -100 | -25,826 | - | -% |
May 15, 2024 | Voya Investment Management LLC | reduced | -21.07 | -406 | 72,222 | -% |
Unveiling Gritstone Oncology Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Gritstone Oncology Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Gritstone Oncology Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -83.2% | 1,742 | 10,382 | 1,565 | 1,955 | 2,443 | 4,262 | 3,021 | 5,471 | 7,191 | 3,064 | 2,614 | 2,843 | 39,693 | 1,348 | 939 | 488 | 1,262 | 884 | 984 | 1,150 | 1,347 |
Operating Expenses | 1.7% | 41,543 | 40,854 | 40,169 | 37,683 | 37,259 | 36,182 | 32,898 | 35,139 | 36,154 | 32,848 | 30,769 | 28,009 | 31,797 | 28,496 | 27,081 | 26,545 | 27,933 | 29,197 | 29,468 | 23,364 | 20,276 |
S&GA Expenses | -100.0% | - | 7,916 | 7,406 | 6,716 | 6,745 | 6,761 | 6,462 | 7,792 | 7,955 | 6,682 | 6,373 | 5,937 | 6,941 | 5,660 | 5,031 | 5,255 | 5,465 | 5,615 | 4,582 | 4,835 | 4,377 |
R&D Expenses | 0.3% | 33,041 | 32,938 | 32,763 | 30,967 | 30,514 | 43,520 | 26,436 | 27,347 | - | 26,166 | 24,396 | 22,072 | 24,856 | 22,836 | 22,050 | 21,290 | 22,468 | 23,582 | 24,886 | 18,529 | 15,899 |
Interest Expenses | 6.5% | 1,296 | 1,217 | 991 | 985 | 844 | 672 | 551 | - | 24.00 | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -31.1% | -40,400 | -30,818 | -38,434 | -35,256 | -33,982 | -31,290 | -29,966 | -29,515 | -28,916 | -29,769 | -28,118 | -25,118 | 7,923 | -27,167 | -26,073 | -25,868 | -26,206 | -27,704 | -27,548 | -21,172 | -18,009 |
Net Income Margin | -9.3% | -9.26* | -8.47* | -13.59* | -11.17* | -8.21* | -6.00* | -6.30* | -6.34* | -7.12* | -1.56* | -1.56* | -1.57* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -70.8% | -33,710 | -19,739 | -32,140 | -32,674 | -41,667 | -31,783 | -26,936 | -27,790 | -35,263 | -25,109 | -16,372 | -24,370 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -22.8% | 137 | 178 | 187 | 223 | 210 | 241 | 205 | 214 | 243 | 278 | 271 | 224 | 247 | 222 | 123 | 146 | 163 | 184 | 209 | 228 | 175 |
Current Assets | -40.7% | 52.00 | 87.00 | 91.00 | 122 | 155 | 183 | 153 | 162 | 193 | 221 | 218 | 177 | 203 | 175 | 74.00 | 94.00 | 112 | 131 | 155 | 185 | 135 |
Cash Equivalents | -22.3% | 49.00 | 63.00 | 30.00 | 41.00 | 47.00 | 55.00 | 77.00 | 80.00 | 84.00 | 111 | 148 | 65.00 | 109 | 171 | 59.00 | 64.00 | 56.00 | 58.00 | 118 | 109 | 36.00 |
Net PPE | -18.5% | 14.00 | 17.00 | 19.00 | 20.00 | 20.00 | 21.00 | 22.00 | 23.00 | 22.00 | 22.00 | 21.00 | 22.00 | 22.00 | 22.00 | 23.00 | 25.00 | 26.00 | 27.00 | 24.00 | 19.00 | 16.00 |
Liabilities | -2.1% | 123 | 126 | 113 | 113 | 69.00 | 70.00 | 68.00 | 51.00 | 54.00 | 62.00 | 63.00 | 45.00 | 48.00 | 55.00 | 51.00 | 49.00 | 48.00 | 50.00 | 52.00 | 46.00 | 43.00 |
Current Liabilities | -5.4% | 26.00 | 27.00 | 23.00 | 22.00 | 25.00 | 35.00 | 32.00 | 32.00 | 34.00 | 40.00 | 36.00 | 21.00 | 22.00 | 27.00 | 22.00 | 19.00 | 18.00 | 20.00 | 23.00 | 18.00 | 14.00 |
Long Term Debt | 0.5% | 40.00 | 40.00 | 30.00 | 30.00 | 30.00 | 19.00 | 19.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 40.00 | 30.00 | 30.00 | 30.00 | 19.00 | 19.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -73.1% | 14.00 | 52.00 | 74.00 | 110 | 141 | 171 | 137 | 163 | 189 | 216 | 208 | 179 | 199 | 167 | 72.00 | 96.00 | 115 | 134 | 156 | 182 | 132 |
Retained Earnings | -6.1% | -699 | -659 | -628 | -590 | -555 | -521 | -489 | -459 | -430 | -401 | -371 | -343 | -318 | -326 | -299 | -273 | -247 | -221 | -193 | -165 | -144 |
Additional Paid-In Capital | 0.4% | 714 | 711 | 703 | 700 | 696 | 692 | 627 | 624 | 620 | 618 | 580 | 522 | 518 | 493 | 371 | 369 | 363 | 355 | 350 | 348 | 277 |
Shares Outstanding | 0.5% | 98.00 | 98.00 | 93.00 | 91.00 | 88.00 | 87.00 | 86.00 | 86.00 | 86.00 | 79.00 | 78.00 | 77.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 174 | - | - | - | 172 | - | - | - | 419 | - | - | - | 199 | - | - | - | 277 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -71.7% | -33,567 | -19,548 | -31,047 | -30,953 | -40,100 | -30,300 | -25,812 | -26,337 | -33,451 | -23,779 | -14,899 | -22,700 | 10,700 | -25,202 | -20,200 | -20,723 | -22,977 | -22,400 | -25,100 | -18,373 | -19,127 |
Share Based Compensation | 15.0% | 3,246 | 2,823 | 2,964 | 2,940 | 2,891 | 3,008 | 3,064 | 3,354 | 3,131 | 2,799 | 2,819 | 2,733 | 2,201 | 1,695 | 1,839 | 1,957 | 1,619 | 1,443 | 1,532 | 1,317 | 1,007 |
Cashflow From Investing | -67.9% | 12,303 | 38,295 | 18,281 | 24,592 | 21,173 | -46,152 | 3,075 | 22,479 | 7,634 | -46,626 | 41,160 | -23,487 | -89,600 | 11,618 | 15,732 | 23,825 | 14,774 | -41,349 | 33,983 | 21,777 | 1,430 |
Cashflow From Financing | -102.4% | -379 | 15,717 | -264 | 1,017 | 8,647 | 64,365 | 19,340 | 310 | -917 | 32,877 | 56,743 | 1,745 | 17,395 | 125,432 | 37.00 | 4,677 | 5,655 | 4,267 | 252 | 69,790 | 86.00 |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Total revenues | $ 1,742 | $ 2,443 |
Operating expenses: | ||
Research and development | 33,041 | 30,514 |
General and administrative | 8,502 | 6,745 |
Total operating expenses | 41,543 | 37,259 |
Loss from operations | (39,801) | (34,816) |
Interest income | 712 | 1,678 |
Interest Expense | (1,296) | (844) |
Net loss | (40,385) | (33,982) |
Other comprehensive loss: | ||
Unrealized (loss) gain on marketable securities | (4) | 28 |
Comprehensive loss | $ (40,389) | $ (33,954) |
Net loss per share, basic | $ (0.34) | $ (0.3) |
Net loss per share, diluted | $ (0.34) | $ (0.3) |
Weighted-average number of shares used in computing net loss per share, basic | 118,391,224 | 114,423,000 |
Weighted-average number of shares used in computing net loss per share, diluted | 118,391,224 | 114,423,000 |
Collaboration and license revenues [Member] | ||
Total revenues | $ 49 | $ 542 |
Grant Revenues [Member] | ||
Total revenues | $ 1,693 | $ 1,901 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 42,395 | $ 62,986 |
Marketable securities | 3,908 | 16,288 |
Restricted cash | 1,247 | 2,299 |
Prepaid expenses and other current assets | 4,303 | 5,862 |
Total current assets | 51,853 | 87,435 |
Long-term restricted cash | 5,290 | 5,290 |
Property and equipment, net | 14,088 | 17,281 |
Lease right-of-use assets | 65,057 | 66,839 |
Deposits and other long-term assets | 924 | 924 |
Total assets | 137,212 | 177,769 |
Current liabilities: | ||
Accounts payable | 7,248 | 3,819 |
Accrued compensation | 4,340 | 9,357 |
Accrued liabilities | 2,141 | 1,213 |
Accrued research and development expenses | 4,045 | 3,696 |
Lease liabilities, current portion | 6,811 | 6,904 |
Deferred revenue, current portion | 1,285 | 2,350 |
Total current liabilities | 25,870 | 27,339 |
Other liabilities, noncurrent | 907 | 709 |
Lease liabilities, net of current portion | 56,141 | 57,727 |
Debt, noncurrent | 40,330 | 40,144 |
Total liabilities | 123,248 | 125,919 |
Commitments and contingencies (Notes 6, 8 and 9) | ||
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding at March 31, 2024 and December 31, 2023 | 0 | 0 |
Common stock, $0.0001 par value; 300,000,000 shares authorized at March 31, 2024 and December 31, 2023; 98,114,860 and 97,585,415 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 22 | 22 |
Additional paid-in capital | 713,889 | 711,386 |
Accumulated other comprehensive (loss) gain | (1) | 3 |
Accumulated deficit | (699,946) | (659,561) |
Total stockholders’ equity | 13,964 | 51,850 |
Total liabilities and stockholders’ equity | $ 137,212 | $ 177,769 |